Carbon Monoxide Poisoning Treatment Device Approved by FDA

To help treat carbon monoxide poisoning, federal regulators have approved a new medical device that is designed to quickly remove carbon monoxide from the body, reducing the risk of brain damage from the toxic gas and increasing the survival odds.

The FDA issued a press release on March 14, to announce the approval of ClearMate, which gives carbon monoxide poisoning victims oxygen and increases their breathing rate. This allows the gas to leave the body faster. The approval was granted to the manufacturer, Thornhill Research, Inc.

“Carbon monoxide poisoning is a serious issue, affecting thousands of people each year,” Dr. Malvina Eydelman, director of the Division of Ophthalmic and Ear, Nose and Throat Devices in the FDA Center for Devices and Radiological Health, said in the press release. “While the current standard treatment of administering 100 percent oxygen through a mask can be done anywhere, hyperbaric treatment, which is necessary for severe carbon monoxide poisoning, is less accessible because there are only 60 medical centers with hyperbaric units in the entire U.S. Moreover, those medical facilities are seldom in rural areas, so treatment in those areas could be delayed considerably due to transport time.”

|
|

The ClearMate is much smaller and portable, consisting of a gas mixer, oxygen reservoir, mask, hoses, valves, meters and breathing circuits. According to the press release, it has undergone multiple clinical studies which tested its safety and effectiveness on a total of 100 patients.

Carbon monoxide is a colorless and odorless gas that is produced by the incomplete burning of various fuels, including coal, wood, charcoal, oil, kerosene, propane, and natural gas. The gas is often referred to as the “silent killer,” since it is difficult to detect without the use of a properly functioning detector or alarm, and is a leading cause of poisoning deaths in the United States.

Due to the inability to detect the gas without the use of a carbon monoxide detector, individuals may be exposed to low levels of the gas over a long period of time, potentially resulting in severe injury or permanent brain damage from carbon monoxide poisoning.

The initial symptoms of carbon monoxide exposure may cause feelings of nausea, headaches, dizziness, drowsiness, and shortness of breath, whereas prolonged exposure may result in mental confusion, vomiting, loss of muscle coordination or control, loss of consciousness, and ultimately death. It is common for individuals to mistake the initial symptoms of CO exposure for the flu, often times prolonging treatment and causing increased adverse health effects.

The FDA indicates that nearly 500 people die every year in the U.S. due to carbon monoxide poisoning, which causes about 20,000 emergency room visits each year.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A panel of federal judges will decide in December whether to consolidate all claims brought by parents who allege that Roblox facilitated child sexual exploitation into a multidistrict litigation.
A federal judge has called for a second census of Suboxone tooth decay lawsuits and will require prompt filing of census forms for claims filed from October 1 forward.
Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm.